Treatment and Survival of 351 Patients Diagnosed with Merkel Cell Carcinoma in 2 Melanoma and Neuroendocrine Tumor Expert-Centers in the Netherlands

#1792

Introduction: Merkel cell carcinoma (MCC) is a rare and potentially aggressive neuroendocrine carcinoma of the skin. Because of its frequency, adequate data on treatment and survival are lacking.

Aim(s): To describe treatment and survival of patients with MCC referred to 2 expert-centers.

Materials and methods: Patients with histologically confirmed MCC in 1990-2014 were included. Data on patient, tumor characteristics and treatment were collected. Primary endpoints were relapse-free survival (RFS), overall survival (OS) and disease-specific survival (DSS).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: van Veenendaal L

Authors: Van Veenendaal L, Van Akkooi A, Verhoef C, Grünhagen D, Klop W,

Keywords: Merkel cell carcinoma, NEC,